Substantial survival increase after highly active antiretroviral therapy for HIV-1 infection

Research published in this week's issue of The Lancet highlights the substantial increased survival for people with HIV-1 since the introduction of highly active antiretroviral therapy (HAART) in 1997. However the study also shows a shift in risk profiles compared with earlier data-people over 45 years no longer appear to have reduced survival compared with younger people, and individuals who acquire HIV-1 infection from injecting drug use have mortality rates four times greater than infection acquired from homosexual contact.

Using data from a large collaboration of 22 studies in Europe, Australia, and Canada (CASCADE), Kholoud Porter from the UK Medical Research Council Clinical Trials Unit and colleagues assessed the continuing effect of HAART on survival and progression to AIDS after HIV-1 seroconversion (the point at which antibodies to HIV-1 infection are detectable in blood). The investigators compared the effects of age at seroconversion, exposure category, sex, and presentation during acute HIV-1 infection pre-1997 (pre-HAART), in 1997-98 (limited use of HAART), and 1999-2001 (widespread use of HAART).

Compared with pre-1997 data, death rates were reduced by 50% in 1997, and by over 80% by 2001; during this time use of HAART therapy increased from 22% in 1997 to 57% in 2001. The largest reduction in mortality occured soon after HAART first became available in 1997.

By contrast with the pre-HAART era, injecting drug users had death rates four times greater in 1999-2001 than men infected through homosexual contact. Whereas pre-1997 the risk of AIDS was higher in those aged 45 years or older at seroconversion than in people who were 16-24 years, there was little evidence of a difference in risk by age in 1999-2001.

Kholoud Porter comments: "Now that HAART therapy is available, 9 out of 10 people infected with HIV-1 can expect to survive more than 10 years, regardless of their age. Earlier diagnosis provides opportunities t

Contact: Joe Santangelo

Page: 1 2

Related medicine news :

1. Substantial increase in breast cancer risk from combination hormone replacement therapy
2. Substantial increase in death rate after bypass surgery for people with anaemia
3. Maxim Phase II Clinical Trial Highlights Substantial Increase In Leukemia-FreeSurvival For Acute Myelogenous Leukemia Patients
4. Hormonal treatment improves survival in high-risk prostate cancer patients
5. Lack of clinical trial participation may contribute to lower survival rates
6. Alcohol relapse adversely affects 10-year liver transplant survival
7. Donor age has no affect on long-term liver transplant survival
8. Specialist care gives better rate of survival
9. Bevacizumab combined with chemotherapy prolongs survival for some patients with advanced lung cancer
10. New treatment options for some difficult cancers improve survival and quality of life
11. Medical technologies may hinder rather than help newborn survival

Post Your Comments:

(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps ... provides a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... received FDA 510(k) clearance in May 2017 for its highly anticipated ... for endoscopy environments. An innovative secondary monitor solution, ZeroWire Mobile ... the improvement of patient outcomes, procedural efficiency, and the lowering of ... ... By ...
(Date:10/7/2017)... 6, 2017   Provista, a proven leader ... billion in purchasing power, today announced a new resource ... The Newsroom is the online home for case ... expert bios, news releases, slideshows and events. ... wealth of resources at their fingertips, viewers can also ...
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare product ... training aide "cprCUBE" on Kickstarter. The device will educate ... cardiac arrests with better efficiency compared to the dated ... real-time feedback on efficacy of the compression for a ... has a goal to raise $5,000. ...
Breaking Medicine Technology:
Cached News: